Data Collection of Routine Clinical Use With the Spectra Optia® Apheresis System for White Blood Cell Depletion (WBCD)

Terumo

Status: Completed

Conditions: Leukocytosis

Treatments: Device: Spectra Optia® Apheresis System

Study type: Observational

Funder types: Industry

Identifiers

NCT02302365

CTS-5043

Details and patient eligibility

About

This study is a multicenter, retrospective data collection of routine clinical use with the Spectra Optia® apheresis system for white blood cell depletion.

Full description

The goal of this study is to gather a broader knowledge and information from routine clinical use on the performance and safety of white blood cell depletion procedures with the Spectra Optia® apheresis system.

In order to do so, retrospective data on white blood cell depletion procedures with the Spectra Optia® apheresis system done in routine use in 3 different centers will be collected and analyzed.

Enrollment: 43 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients having received a minimum of 1 white blood cell depletion procedure via the Spectra Optia Apheresis System

Exclusion criteria

• none

Trial design